en tête innovation recherche oncopole

Innovation and Partnerships

Pierre Fabre, a Group always open to partnerships involving the development of new therapeutic or dermo-cosmetic solutions. Discover our passion for open innovation!

Partnerships which change
the game

Array Biopharma

Array BioPharma

November 16, 2015: an international partnership was signed with the American biotech Array BioPharma to develop and market a combination of two new molecules in the field of oncology. After positive results from clinical studies, the new prescription drug was launched. A big step for patients with advanced melanoma, and new hope for patients in other indications with the ongoing pursuit of promising clinical studies.

Range of products from Meme Cosmetics

MÊME Cosmetics

January 9, 2018: Pierre Fabre Dermo-Cosmetics and the young start-up MÊME Cosmetics signed a partnership. The two partners combined their talents to improve quality of life for women on anti-cancer drugs by offering them adapted beauty treatments. A human alliance founded on the same high standards and the same desire to listen to patients and take a patient-centric approach.

Partenaires - bannière


Searching (further), innovating (better)



Pierre Fabre Pharmaceuticals devotes around 15% of its revenue to R&D in oncology, medical dermatology, family health and oral health. This involves taking a substantial risk, which, going far beyond good intentions, is an indication of our desire to offer new therapeutic solutions to patients and their doctors.


Go to pharma R&D



Hydration, reactive skin, pigmentation, sun protection, hair biology, epidermal aging… More than 200 employees work on research every day at Pierre Fabre Dermo-Cosmetics. Their purpose: to push boundaries in the understanding of the skin and hair to offer innovative dermo-cosmetic solutions.


Go to dermo-cosmetics R&D